|
|
|
Volumn 105, Issue 11, 2002, Pages
|
|
Angiogenic gene therapy appears safe to treat stable angina.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBROBLAST GROWTH FACTOR;
FIBROBLAST GROWTH FACTOR 14;
FIBRINOLYTIC AGENT;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
AZITHROMYCIN;
C REACTIVE PROTEIN;
ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;
VON WILLEBRAND FACTOR;
ANGINA PECTORIS;
DRUG EFFECT;
EXERCISE TOLERANCE;
GENE THERAPY;
GENE VECTOR;
GENETICS;
HUMAN;
NOTE;
TREATMENT OUTCOME;
AGE;
AGED;
DRUG CONTRAINDICATION;
HEART INFARCTION;
MORTALITY;
RISK ASSESSMENT;
BACTERIAL INFECTION;
BLOOD;
BRACHIAL ARTERY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CORONARY ARTERY ATHEROSCLEROSIS;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
VASODILATATION;
ANGINA PECTORIS;
EXERCISE TOLERANCE;
FIBROBLAST GROWTH FACTORS;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
TREATMENT OUTCOME;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
FIBRINOLYTIC AGENTS;
HOSPITAL MORTALITY;
MYOCARDIAL INFARCTION;
RISK ASSESSMENT;
STREPTOKINASE;
TISSUE PLASMINOGEN ACTIVATOR;
AZITHROMYCIN;
BRACHIAL ARTERY;
C-REACTIVE PROTEIN;
CHLAMYDOPHILA INFECTIONS;
CORONARY ARTERIOSCLEROSIS;
E-SELECTIN;
RANDOMIZED CONTROLLED TRIALS;
VASODILATION;
VON WILLEBRAND FACTOR;
|
|
EID: 0037133803
PISSN: 15244539
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
